HERAN Partners

Venture Capital 64/5 Antwerp, Belgium ·Founded 2020

Overview

HERAN Partners is a Belgium-based venture capital firm committed to creating transformative impact within the healthcare and life sciences industry. The firm provides venture and growth capital, accompanied by a strong network, expertise, and mentorship, to startups and scale-ups with solid technology platforms and strong market potential. Their investment philosophy centers around addressing emerging health challenges such as an aging population, the surge in chronic diseases, and the associated increase in healthcare costs. They focus on solutions that are solving unmet needs in the market. The firm's investment approach is built upon three strategic pillars centered around enabling technologies: MedTech, HealthTech, and Digital Health. In MedTech, they invest in creating efficiencies through lab equipment and services, diagnostic analysis platforms, and multi-omics technologies. In HealthTech, they leverage software and data to create innovative solutions. In Digital Health, they focus on the integration of technology into healthcare services to improve patient outcomes and operational efficiencies. HERAN Partners has an impressive track record of investments in various companies. Notably, they co-led a €5 million seed investment in Nuclivision, a Belgian company developing AI-driven software solutions for nuclear medicine applications. They also invested in Amaron, a Belgian healthcare IT company specializing in data exchange platforms for hospitals. Additionally, they have invested in Gynaia, a women's health diagnostics company, and Nuclivision, a developer of software solutions for nuclear imaging. These investments reflect their commitment to supporting innovative companies that aim to have a transformative impact on healthcare and life sciences.

Investment Focus

  • Strong technology platform
  • Strong market potential
  • Innovative solutions addressing unmet needs in healthcare and life sciences

Portfolio Companies

NuclivisionAmaronGynaia

Reach HERAN Partners directly

Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.

Unlock full contacts →

Frequently asked questions about HERAN Partners

What sectors does HERAN Partners invest in?

HERAN Partners invests in Healthcare, Software, HealthTech, Artificial Intelligence, Life Sciences and Digital Health, and is based in 64/5 Antwerp, Belgium. HERAN Partners is listed as a venture capital in the ConnectSafely investor database.

What stage does HERAN Partners invest at?

HERAN Partners backs companies at Seed, Early Stage and Growth, writing cheques of 2M - 5M.

Which regions does HERAN Partners invest in?

HERAN Partners invests across United States, United Kingdom, Netherlands and Belgium.

Who are the partners at HERAN Partners?

Team members listed for HERAN Partners include Joris Mortelmans (Partner/CFO) and Katleen Vandersmissen (Managing Partner).

What companies has HERAN Partners invested in?

HERAN Partners's portfolio includes Nuclivision, Amaron and Gynaia.

How do I contact HERAN Partners?

HERAN Partners's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.

Last updated · Source: ConnectSafely investor database